Literature DB >> 23147039

Alveolar epithelial cells are critical in protection of the respiratory tract by secretion of factors able to modulate the activity of pulmonary macrophages and directly control bacterial growth.

Olga D Chuquimia1, Dagbjort H Petursdottir, Natalia Periolo, Carmen Fernández.   

Abstract

The respiratory epithelium is a physical and functional barrier actively involved in the clearance of environmental agents. The alveolar compartment is lined with membranous pneumocytes, known as type I alveolar epithelial cells (AEC I), and granular pneumocytes, type II alveolar epithelial cells (AEC II). AEC II are responsible for epithelial reparation upon injury and ion transport and are very active immunologically, contributing to lung defense by secreting antimicrobial factors. AEC II also secrete a broad variety of factors, such as cytokines and chemokines, involved in activation and differentiation of immune cells and are able to present antigen to specific T cells. Another cell type important in lung defense is the pulmonary macrophage (PuM). Considering the architecture of the alveoli, a good communication between the external and the internal compartments is crucial to mount effective responses. Our hypothesis is that being in the interface, AEC may play an important role in transmitting signals from the external to the internal compartment and in modulating the activity of PuM. For this, we collected supernatants from AEC unstimulated or stimulated in vitro with lipopolysaccharide (LPS). These AEC-conditioned media were used in various setups to test for the effects on a number of macrophage functions: (i) migration, (ii) phagocytosis and intracellular control of bacterial growth, and (iii) phenotypic changes and morphology. Finally, we tested the direct effect of AEC-conditioned media on bacterial growth. We found that AEC-secreted factors had a dual effect, on one hand controlling bacterial growth and on the other hand increasing macrophage activity.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23147039      PMCID: PMC3536158          DOI: 10.1128/IAI.00950-12

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  58 in total

1.  A role for dendritic cells in the dissemination of mycobacterial infection.

Authors:  Ian R Humphreys; Graham R Stewart; David J Turner; Janisha Patel; Danai Karamanou; Robert J Snelgrove; Douglas B Young
Journal:  Microbes Infect       Date:  2006-03-24       Impact factor: 2.700

2.  Distinct differentiation potential of blood monocyte subsets in the lung.

Authors:  Limor Landsman; Chen Varol; Steffen Jung
Journal:  J Immunol       Date:  2007-02-15       Impact factor: 5.422

3.  Lung macrophages serve as obligatory intermediate between blood monocytes and alveolar macrophages.

Authors:  Limor Landsman; Steffen Jung
Journal:  J Immunol       Date:  2007-09-15       Impact factor: 5.422

4.  Human {beta}-defensin 2 is expressed and associated with Mycobacterium tuberculosis during infection of human alveolar epithelial cells.

Authors:  Bruno Rivas-Santiago; Stephan K Schwander; Carmen Sarabia; Gill Diamond; Marcia E Klein-Patel; Rogelio Hernandez-Pando; Jerrold J Ellner; Eduardo Sada
Journal:  Infect Immun       Date:  2005-08       Impact factor: 3.441

5.  Differential regulation of cytokine release and leukocyte migration by lipopolysaccharide-stimulated primary human lung alveolar type II epithelial cells and macrophages.

Authors:  Andrew J Thorley; Paul A Ford; Mark A Giembycz; Peter Goldstraw; Alan Young; Teresa D Tetley
Journal:  J Immunol       Date:  2007-01-01       Impact factor: 5.422

6.  Alveolar epithelial cells direct monocyte transepithelial migration upon influenza virus infection: impact of chemokines and adhesion molecules.

Authors:  Susanne Herold; Werner von Wulffen; Mirko Steinmueller; Stephan Pleschka; William A Kuziel; Matthias Mack; Mrigank Srivastava; Werner Seeger; Ulrich A Maus; Juergen Lohmeyer
Journal:  J Immunol       Date:  2006-08-01       Impact factor: 5.422

7.  Proinflammatory response of alveolar epithelial cells is enhanced by alveolar macrophage-produced TNF-alpha during pulmonary ischemia-reperfusion injury.

Authors:  Ashish K Sharma; Lucas G Fernandez; Alaa S Awad; Irving L Kron; Victor E Laubach
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2007-04-06       Impact factor: 5.464

8.  CCR2+ monocyte-derived dendritic cells and exudate macrophages produce influenza-induced pulmonary immune pathology and mortality.

Authors:  Kaifeng Lisa Lin; Yasushi Suzuki; Hideki Nakano; Elizabeth Ramsburg; Michael Dee Gunn
Journal:  J Immunol       Date:  2008-02-15       Impact factor: 5.422

9.  Alveolar epithelial type II cells induce T cell tolerance to specific antigen.

Authors:  Bernice Lo; Soren Hansen; Kathy Evans; John K Heath; Jo Rae Wright
Journal:  J Immunol       Date:  2008-01-15       Impact factor: 5.422

10.  CCR2 and CXCR3 agonistic chemokines are differently expressed and regulated in human alveolar epithelial cells type II.

Authors:  Dmitri V Pechkovsky; Torsten Goldmann; Corinna Ludwig; Antje Prasse; Ekkehard Vollmer; Joachim Müller-Quernheim; Gernot Zissel
Journal:  Respir Res       Date:  2005-07-20
View more
  41 in total

1.  Gene expression profiling of the effects of organic dust in lung epithelial and THP-1 cells reveals inductive effects on inflammatory and immune response genes.

Authors:  Vijay Boggaram; David S Loose; Koteswara R Gottipati; Kartiga Natarajan; Courtney T Mitchell
Journal:  Physiol Genomics       Date:  2016-02-16       Impact factor: 3.107

Review 2.  Alveolar Epithelial Cells in Mycobacterium tuberculosis Infection: Active Players or Innocent Bystanders?

Authors:  Julia M Scordo; Daren L Knoell; Jordi B Torrelles
Journal:  J Innate Immun       Date:  2015-09-18       Impact factor: 7.349

3.  The Nod1, Nod2, and Rip2 axis contributes to host immune defense against intracellular Acinetobacter baumannii infection.

Authors:  Pradeep Bist; Neha Dikshit; Tse Hsien Koh; Alessandra Mortellaro; Thuan Tong Tan; Bindu Sukumaran
Journal:  Infect Immun       Date:  2013-12-23       Impact factor: 3.441

4.  Deletion of P2X7 attenuates hyperoxia-induced acute lung injury via inflammasome suppression.

Authors:  Lakshmi Galam; Ashna Rajan; Athena Failla; Ramani Soundararajan; Richard F Lockey; Narasaiah Kolliputi
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2016-01-08       Impact factor: 5.464

5.  LPS-treated macrophage cytokines repress surfactant protein-B in lung epithelial cells.

Authors:  Kiflai Bein; Michelangelo Di Giuseppe; Steven E Mischler; Luis A Ortiz; George D Leikauf
Journal:  Am J Respir Cell Mol Biol       Date:  2013-08       Impact factor: 6.914

6.  Lipidomic characterization and localization of phospholipids in the human lung.

Authors:  Karin A Zemski Berry; Robert C Murphy; Beata Kosmider; Robert J Mason
Journal:  J Lipid Res       Date:  2017-03-09       Impact factor: 5.922

7.  Alveolar Epithelial Cell-Derived Prostaglandin E2 Serves as a Request Signal for Macrophage Secretion of Suppressor of Cytokine Signaling 3 during Innate Inflammation.

Authors:  Jennifer M Speth; Emilie Bourdonnay; Loka Raghu Kumar Penke; Peter Mancuso; Bethany B Moore; Jason B Weinberg; Marc Peters-Golden
Journal:  J Immunol       Date:  2016-05-13       Impact factor: 5.422

8.  IL-12+IL-18 Cosignaling in Human Macrophages and Lung Epithelial Cells Activates Cathelicidin and Autophagy, Inhibiting Intracellular Mycobacterial Growth.

Authors:  Rui Yang; Enzhuo Yang; Ling Shen; Robert L Modlin; Hongbo Shen; Zheng W Chen
Journal:  J Immunol       Date:  2018-02-16       Impact factor: 5.422

Review 9.  Innate receptors and cellular defense against pulmonary infections.

Authors:  Jessica L Werner; Chad Steele
Journal:  J Immunol       Date:  2014-10-15       Impact factor: 5.422

Review 10.  The microbiome at the pulmonary alveolar niche and its role in Mycobacterium tuberculosis infection.

Authors:  Alexander J Adami; Jorge L Cervantes
Journal:  Tuberculosis (Edinb)       Date:  2015-07-30       Impact factor: 3.131

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.